AIM:AIM ImmunoTech Inc Snapshot | Charting | News | Options
$1.02 NYSE MKT LLC 10:41a ET
March 18 '26 		Biotech Breakthroughs and Strategic Pivots Fuel Market Momentum GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Biotech Breakthroughs and Strategic Pivots Fuel Market Momentum
     GlobeNewswire
    Full Story →

    Headline News
    AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors
    8:36a ET March 18 '26 GlobeNewswire
    AIM ImmunoTech Announces Closing of its Rights Offering
    7:00p ET March 6 '26 GlobeNewswire
    AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million
    9:00a ET March 4 '26 GlobeNewswire
    More News →
    Day  43.7%Week  51.0%Month  18.40%More Charting →
    March 18 '26. Markets Closed.
    Last $1.02
    Day change   43.66%$0.31
    Open $1.45
    Gap at open $0.74
    Previous close $0.71
    Trading volume 185,653,962
    10 Day avg vol. 18,706,485
    Shares out. 4.2Mil
    Market cap. $4.3Mil
    Trading activity Above Avg.
    Previous data from yesterday, March 17 '26.

    Historical Price Performance
    3 month   22.65% 
    6 month   60.73% 
    1 year   91.08% 
    2 year   97.19% 

    Earnings
    Previous 12m -$19.82
    Next 12m Estimate -$7.28
    P/E ratio --
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2026 All rights reserved.